HEMOPHILIA A OR B

Clinical trials for HEMOPHILIA A OR B explained in plain language.

Never miss a new study

Get alerted when new HEMOPHILIA A OR B trials appear

Sign up with your email to follow new studies for HEMOPHILIA A OR B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug aims to prevent bleeding in hemophilia patients

Disease control Recruiting now

This study tests a new medicine called KN057 given regularly to prevent bleeding episodes in people with hemophilia A or B, including those whose bodies have developed resistance to standard treatments. About 70 males aged 12 to 65 will receive weekly injections for up to 52 week…

Matched conditions: HEMOPHILIA A OR B

Phase: PHASE3 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Disease control

Last updated May 17, 2026 10:11 UTC

HEMOPHILIA A OR B

Get alerted when new HEMOPHILIA A OR B trials appear

New drug aims to prevent bleeding in hemophilia patients